- Home
- LSTA vs ADVB Comparison
LSTA vs ADVB Comparison
Compare LSTA & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- ADVB
- Stock Information
- Founded
- LSTA 1980
- ADVB 2014
- Country
- LSTA United States
- ADVB United States
- Employees
- LSTA N/A
- ADVB N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- ADVB Medical Specialities
- Sector
- LSTA Health Care
- ADVB Health Care
- Exchange
- LSTA Nasdaq
- ADVB Nasdaq
- Market Cap
- LSTA 24.1M
- ADVB 20.8M
- IPO Year
- LSTA N/A
- ADVB 2025
- Fundamental
- Price
- LSTA $2.61
- ADVB N/A
- Analyst Decision
- LSTA Strong Buy
- ADVB
- Analyst Count
- LSTA 1
- ADVB 0
- Target Price
- LSTA $15.00
- ADVB N/A
- AVG Volume (30 Days)
- LSTA 15.8K
- ADVB 147.6K
- Earning Date
- LSTA 08-11-2025
- ADVB 08-03-2025
- Dividend Yield
- LSTA N/A
- ADVB N/A
- EPS Growth
- LSTA N/A
- ADVB N/A
- EPS
- LSTA N/A
- ADVB N/A
- Revenue
- LSTA $1,000,000.00
- ADVB N/A
- Revenue This Year
- LSTA N/A
- ADVB N/A
- Revenue Next Year
- LSTA N/A
- ADVB N/A
- P/E Ratio
- LSTA N/A
- ADVB N/A
- Revenue Growth
- LSTA N/A
- ADVB N/A
- 52 Week Low
- LSTA $1.87
- ADVB $0.56
- 52 Week High
- LSTA $4.20
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- LSTA 50.61
- ADVB N/A
- Support Level
- LSTA $2.36
- ADVB N/A
- Resistance Level
- LSTA $3.07
- ADVB N/A
- Average True Range (ATR)
- LSTA 0.23
- ADVB 0.00
- MACD
- LSTA 0.02
- ADVB 0.00
- Stochastic Oscillator
- LSTA 37.50
- ADVB 0.00
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.